Regenerative Medicine Firm Reports Early Results from COVID-19 Trials: https://t.co/EdlRsDhuBf

Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report.

$PSTI #covid19 #healthcare #stocks @Pluristem https://t.co/nD6wDG6Th9